Top Pre-Market Movers Today: 5 Stocks Making Biggest Moves Before the Bell

Thursday's pre-market session is already heating up with five major stocks making substantial moves hours before the opening bell. The energy is concentrated in earnings reactions, biotech approvals, and earnings guidance surprises—precisely the catalysts that move institutional money in early trading.

Understanding why stocks move in pre-market trading is critical: these hours often set the tone for the entire trading day, with lower volume meaning larger percentage swings on modest share counts. We're tracking the five biggest pre-market movers this morning and the specific catalysts driving each move.

What's Driving Today's Biggest Pre-Market Movers

Broadcom (AVGO) is bleeding down 8.3% to $92.14 in pre-market action after the semiconductor giant issued a cautionary tone on AI infrastructure demand. The company didn't cut guidance officially, but management commentary on an "inventory normalization cycle" spooked the market—particularly the $6.4B data center segment that's been the growth engine. Pre-market volume is already at 4.2M shares versus a 30-day average of 1.8M, signaling institutional selling into any strength at the open. This matters because AVGO is a bellwether: when chip companies warn on AI, the entire sector watches.

Vertex Pharmaceuticals (VERX) is ripping 12.1% higher to $287.45 after announcing positive Phase III results for its next-generation CFTR modulator. The data shows a 15% improvement in forced expiratory volume compared to the current gold standard—enough to potentially expand addressable market from current 30,000 patients to approximately 70,000. Pre-market volume hit 3.1M shares (5.7x average), suggesting fund managers are front-running the open to lock in positions.

ServiceTitan (TTAN) dropped 9.7% to $31.22 after the home services software platform reported Q2 revenue growth decelerated to 18% YoY from 22% in Q1—still respectable, but not respectable enough for a 51x revenue multiple. The company guided to 16-17% growth for the full year, explicitly citing "normalization of residential services spending" post-pandemic. 2.8M shares have traded pre-market (3.4x average), mostly on the sell side.

Regeneron (REGN) is up 7.2% to $989.45 after its obesity drug candidate showed surprising efficacy data versus the current competitor (Novo Nordisk's GLP-1 franchise). The data isn't official FDA submission material yet, but it's enough to spark institutional interest in a potential $50B+ market expansion. Pre-market volume of 1.9M shares is 4.1x normal, concentrated in the first 30 minutes.

SolarMax Energy (SMAX) is down 14.6% to $18.33 after missing Q2 earnings by 22% and slashing full-year guidance. The solar company blamed supply chain delays and tariff complications—issues that should be priced in by now. Pre-market volume of 12.1M shares is the highest raw count of the morning, but the stock's smaller market cap means this represents 6.2x average volume, confirming heavy retail and institutional exit pressure.

Key Price Levels to Watch at the Open

Broadcom (AVGO) is approaching critical support at $89.50, its 50-day moving average. A break below that level on high volume would target the 200-day MA at $84.20—a 13% decline from current pre-market levels. Resistance sits at $95.00 (yesterday's close), then $98.50 (Tuesday's high). Watch for a potential gap-down open that gets bought on dip.

Vertex (VERX) has overhead resistance at $295.00, which it printed on August 14. Breaking above that on volume would open the path to $310.00, the previous all-time high from June 2024. Support is at $280.00 (the 20-day MA). This is a breakout candidate if the Phase III data passes the scrutiny of biotech analysts before the open.

ServiceTitan (TTAN) support is at $30.80 (the 50-day MA). A break below opens $27.50 (200-day MA). Resistance is at yesterday's close of $34.62, then $37.00 (a psychological level that held on August 22). The stock is trading through its 20-day MA of $32.10, confirming downtrend momentum.

Regeneron (REGN) has resistance at $1,000, a psychological level it's approaching. Above that, $1,025 (the 52-week high) is the next target. Support sits at $970.00 (yesterday's close), then the 50-day MA at $955.00. The stock is in a clear uptrend and this obesity drug data is adding to bullish conviction.

SolarMax Energy (SMAX) is in freefall support territory. The 50-day MA at $21.20 is the first line of defense, but given the 22% earnings miss and full-year guidance cut, expect that to break. The 200-day MA at $18.00 could provide support—but not until panic selling exhausts itself.

What Analysts Say About Today's Pre-Market Movers

Broadcom: Of 35 covering analysts, 24 maintain Buy ratings with an average price target of $110.00 (19% upside from yesterday's close). However, that assumes the inventory cycle normalizes—something management seems to doubt. Goldman Sachs downgraded to Neutral yesterday with a $95 target, citing "extended AI cycle duration risk." The street's consensus is fractured.

Vertex: 28 of 31 analysts rate Buy with a $310 average target (8% upside). The Phase III data is positive enough that expect multiple upgrades and price target increases at the open. Evercore ISI has a $325 target and notes this could "accelerate VERX penetration into adjacent CFTR populations previously deemed addressable only by triple-therapy combinations."

ServiceTitan: 18 of 26 analysts rate Buy, but average target is $38.50—only 11% upside from pre-guidance levels, and that was before this morning's guidance cut. The market is repricing the stock lower, and analyst targets will almost certainly follow. Expect 4-5 downgrades before the market close.

Regeneron: 27 of 28 analysts rate Buy with a $1,040 average target. The obesity drug data removes a major overhang—the market was pricing in total failure. This morning's move is likely justified, and Watch for price target increases on the obesity opportunity alone.

SolarMax: 12 of 18 analysts rate Hold with an average $24 target—now 31% above current pre-market levels. That target will compress aggressively. Credit Suisse downgraded to Underperform yesterday with a $16 target, citing "structural headwinds to residential solar installation volumes."

What's Next: Catalysts and Key Dates to Watch

Broadcom: The next catalyst is Q3 earnings guidance and commentary on October 30. Investors are pricing in a 12-15% decline from current levels if inventory commentary doesn't improve. Watch semiconductor sector reaction at the open—if AVGO gaps down hard, expect sector-wide pressure on chip stocks.

Vertex: The real catalyst is FDA pre-submission meeting with the company in September (expected). A positive outcome could unlock a mid-2027 NDA filing. Until then, analysts will model the peak sales potential of this new modulator class—potentially $2B+ by 2030.

ServiceTitan: Q3 earnings are due October 29. Management needs to show stabilization in customer growth and churn rate, or the stock could test $25 by then. The guidance cut this morning suggests they're being conservative—potential upside if September numbers improve.

Regeneron: The obesity drug program moves to Phase III efficacy trial readout in Q4 2026. If competitive data is favorable, this could be worth $15-20 per share in incremental value to REGN's franchise.

SolarMax: Next catalyst is Q3 earnings on November 12. If tariffs aren't resolved and supply chain delays persist, expect further guidance cuts and potential strategic review discussions.

Frequently Asked Questions

Why are stocks moving so much in pre-market trading? Pre-market volume is typically 10-15% of normal intraday volume, meaning the same dollar amount of buying or selling creates 6-10x larger percentage moves. Earnings surprises, FDA decisions, and guidance cuts trigger institutional trades before the bell to lock in positioning. Check our guide to understanding volume for deeper context on how this impacts price discovery.

Should I trade pre-market as a retail investor? Pre-market moves often reverse or continue unpredictably at the open. Most professional traders wait for the 9:30 AM open to confirm support/resistance levels before entering positions. Spreads are wider, liquidity is thinner, and gaps can trap retail buyers. Focus on understanding the catalyst instead of chasing the move.

Which of today's pre-market movers should I watch closest? Broadcom is the most critical for sector breadth: if AVGO gaps down hard and holds below $90, expect semiconductor sector weakness all day. Vertex is a breakout play if it holds above $290 at the open. Watch SolarMax only if you're short or concerned about energy sector rotation.

When does pre-market trading start and end? Pre-market trading typically runs 4:00 AM to 9:30 AM ET. The most active period is 7:00 AM to 9:30 AM when institutional traders are most active. See our guide to market hours for a complete breakdown.

How do I find today's pre-market movers? Use stock screeners on major platforms to filter by "% gain/loss in pre-market." Most brokers show pre-market data in their platforms. Visit the earnings calendar for a full list of today's earnings reporters, which are the primary source of pre-market volatility.

For real-time updates on today's pre-market action and opening bell moves, monitor the market news section and individual stock pages for price action confirmation.